TD Asset Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,883
Closed -$123K 1516
2021
Q4
$123K Buy
1,883
+941
+100% +$91.3K ﹤0.01% 1466
2021
Q3
$133K Hold
942
﹤0.01% 1498
2021
Q2
$108K Sell
942
-1,932
-67% -$241K ﹤0.01% 1499
2021
Q1
$487K Buy
2,874
+242
+9% +$51K ﹤0.01% 1402
2020
Q4
$535K Sell
2,632
-616
-19% -$119K ﹤0.01% 1320
2020
Q3
$626K Hold
3,248
﹤0.01% 1193
2020
Q2
$888K Buy
3,248
+122
+4% +$32.5K ﹤0.01% 1094
2020
Q1
$874K Sell
3,126
-510
-14% -$156K ﹤0.01% 1037
2019
Q4
$1.35M Sell
3,636
-151
-4% -$43.2K ﹤0.01% 1027
2019
Q3
$1.23M Buy
3,787
+1,114
+42% +$379K ﹤0.01% 1012
2019
Q2
$942K Buy
2,673
+1,125
+73% +$442K ﹤0.01% 1061
2019
Q1
$773K Buy
1,548
+211
+16% +$94.3K ﹤0.01% 1092
2018
Q4
$538K Buy
1,337
+50
+4% +$18.9K ﹤0.01% 1208
2018
Q3
$530K Buy
1,287
+61
+5% +$20.7K ﹤0.01% 1276
2018
Q2
$450K Hold
1,226
﹤0.01% 1284
2018
Q1
$413K Buy
+1,226
New +$412K ﹤0.01% 1235

Other funds holding QTTB

TD Asset Management's QTTB Position: Q1 2022 in Review

TD Asset Management sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 1,883 shares — an estimated $123K sold.

TD Asset Management first reported a position in QTTB in Q1 2018 and held it in 16 quarters. The position peaked at $1.35M in Q4 2019. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • TD Asset Management reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • TD Asset Management sold 1,883 Q32 Bio shares in Q1 2022, an estimated $123K.
  • TD Asset Management first reported a position in Q32 Bio in Q1 2018 and held it in 16 quarters.
  • TD Asset Management's Q32 Bio position peaked at $1.35M in Q4 2019.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.